# Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE)

> **NCT05155137** · PHASE3 · RECRUITING · sponsor: **Hospital Moinhos de Vento** · enrollment: 8518 (estimated)

## Conditions studied

- Stroke
- Cognitive Decline

## Interventions

- **DRUG:** Drug Capsule (Valsartan + Amlodipine + Rosuvastatin)
- **BEHAVIORAL:** Stroke Riskometer

## Key facts

- **NCT ID:** NCT05155137
- **Lead sponsor:** Hospital Moinhos de Vento
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-20
- **Primary completion:** 2029-12-14
- **Final completion:** 2030-12-14
- **Target enrollment:** 8518 (ESTIMATED)
- **Last updated:** 2025-01-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05155137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05155137, "Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05155137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*